数字健康干预对心力衰竭门诊患者的影响:一项随机对照试验
David O Arnar1,2, Bartosz Dobies3,4, Elias F Gudmundsson3
1Cardiovascular Services, Landspitali-The National University Hospital of Iceland, Hringbraut Reykjavik 101, Iceland.
European heart journal. Digital health
|July 24, 2025
概括
一个数字健康计划改善了心力衰竭患者的自我护理和知识,以及像甘油三和HbA1c这样的代谢标志物,尽管它没有显著影响整体生活质量.
科学领域:
- 心脏病学 心脏病学
- 数字健康数字健康
- 健康结果的健康结果.
背景情况:
- 心力衰竭 (HF) 显著增加死亡率并降低生活质量 (QoL).
- 生活方式干预和自我护理管理对于减少HF发病率和住院治疗至关重要.
- 数字健康计划提供了一种新的方法来支持患有慢性疾病的患者.
研究的目的:
- 评估一个全面的数字健康计划对HF患者的QoL和临床结果的影响.
- 评估远程患者监测 (RPM),自我护理教育和生活方式指导的有效性.
- 确定特定的患者子组,这些患者可能会从数字健康干预中获益最多.
主要方法:
- 一项随机对照试验 (RCT) 涉及175名高压患者.
- 干预组接受了标准护理以及数字健康计划;对照组仅接受了标准护理.
- 干预包括RPM,自我护理模块,HF教育和12个月的生活方式支持 (6个月活跃,6个月维护).
主要成果:
- 两组之间与健康相关的整体QOL没有显著差异.
- 探索性分析显示,干预组 (P=0.023) 的NYHAIII类患者的QOL下降有所减少.
- 干预组的自我护理 (P<0.001在6个月,P=0.003在12个月) 和疾病知识 (P=0.001在12个月) 显著改善.
- 观察到的新陈代谢改善:甘油三 (P=0.012),HbA1c (P=0.014),禁食葡萄糖 (P=0.010),以及Tg/HDL比率.
结论:
- 数字健康计划提高了HF患者的自我护理,知识和关键代谢参数.
- 虽然干预措施没有改善整体体质量,但在特定子组和某些临床标志物中显示出有前途.
- 数字健康策略可以成为管理心力衰竭的有价值的辅助工具,特别是在改善坚持和代谢控制方面.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
215
相关概念视频
01:30Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
01:30Heart Failure VII: Nursing Interventions
140
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
140
01:22Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
01:22Heart Failure Drugs: β-Blockers
435
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
435
01:22Heart Failure Drugs: Diuretics
495
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
495